alternatives to Zelnorm now that it's being pulled from the market for possible cardiovascular problems

Patients are scrambling for alternatives to Zelnorm now that it's being pulled from the market for possible cardiovascular problems.

Zelnorm (tegaserod) is associated with a 0.1% increase in cardiovascular events...compared to a 0.01% placebo rate.

Zelnorm's benefits are modest.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote